• Hormonal therapy and cognitive function

    Preliminary results from a University of Toronto study indicate that androgen deprivation therapy (ADT) does not affect most cognitive domains, and may even be associated with a slight improvement

  • Benefits stacking up in statin studies

     Recent studies suggest that statins may benefit several aspects of prostate health. Statins are drugs commonly used to lower cholesterol; laboratory studies have also observed that they prevent cancer cells from dividing and may cause some cancer cells to die. Here’s a look at a few significant studies...

  • Hopes dashed for supplements

    A new Canadian study confirms that the combination of vitamin E, selenium and soy — long touted as promising supplements to prevent prostate cancer — does not stop high-grade prostatic intraepithelial neoplasia (PIN; a possible precursor to cancer) from progressing to prostate cancer. The study,...

  • Vaccine milestone

     A presentation at the American Urological Association (AUA) Annual Meeting in Chicago in April 2009 reported significant results for an investigational therapy for men with advanced prostate cancer. Provenge® — a customized vaccine made partly from the patient’s own blood cells — works...

  • “Curative” hormone therapy?

    Traditionally, hormonal therapies such as goserelin, leuprolide and triptorelin (LHRH agonists or analogs) are used to manage advanced or recurrent prostate cancer. These drugs block the release of luteinizing hormone-releasing hormone, a hormone involved in producing testosterone, which fuels prostate cancer cell...